On March 7th, in the presence of the Prefect, Murielle Cazaubiel, manager of Biofortis Merieux Nutrisciences, received the insignia of... View Article
Author Archives for Adeline Chauvigné
Murielle Cazaubiel elevated to the rank of Knight of the Legion of Honor
9 May 2025On March 7th, in the presence of the Prefect, Murielle Cazaubiel, manager of Biofortis Merieux Nutrisciences, received the insignia of... View Article
Join the Bioregate Forum 2016 in Nantes!
Bioregate Forum is a biannual European meeting dedicated to highlighting latest scientific, technological, clinical & commercialization approaches in the field... View Article
Join the Bioregate Forum 2016 in Nantes!
9 May 2025Bioregate Forum is a biannual European meeting dedicated to highlighting latest scientific, technological, clinical & commercialization approaches in the field... View Article

Effimune & Ose Pharma announce proposed merger to create significan immunotherapy player
OSE Pharma, an immuno-oncology company with a specific immunotherapy activating T lymphocytes, currently in a registration Phase 3 study, and Effimune, a... View Article

Effimune & Ose Pharma announce proposed merger to create significan immunotherapy player
9 May 2025OSE Pharma, an immuno-oncology company with a specific immunotherapy activating T lymphocytes, currently in a registration Phase 3 study, and Effimune, a... View Article

Valneva Announces $42 Million IXIARO® Supply Contract with US Government
Valneva SE (“Valneva” or “the Company”), a leading pure play vaccine company, announces today the signing of a $42 million... View Article

Valneva Announces $42 Million IXIARO® Supply Contract with US Government
9 May 2025Valneva SE (“Valneva” or “the Company”), a leading pure play vaccine company, announces today the signing of a $42 million... View Article

Effimune and In Cell Art collaborate to develop a novel therapeutic approach in immunology
PR 110216Final The two biotechnology companies in Nantes develop a novel approach aiming at the production of therapeutic antibodies directly... View Article

Effimune and In Cell Art collaborate to develop a novel therapeutic approach in immunology
9 May 2025PR 110216Final The two biotechnology companies in Nantes develop a novel approach aiming at the production of therapeutic antibodies directly... View Article
Atlanpole Biotherapies joins CEBR Board
The Council of European BioRegions (CEBR) is a network of biotechnology support professionals that support their local biocommunity through direct services including... View Article
Atlanpole Biotherapies joins CEBR Board
9 May 2025The Council of European BioRegions (CEBR) is a network of biotechnology support professionals that support their local biocommunity through direct services including... View Article

Porsolt expands with the acquisition of Fluofarma
Porsolt has acquired Fluofarma, a Bordeaux-based company focused on the provision of cell-based assays and in vitro screening services. The... View Article

Porsolt expands with the acquisition of Fluofarma
9 May 2025Porsolt has acquired Fluofarma, a Bordeaux-based company focused on the provision of cell-based assays and in vitro screening services. The... View Article

IFB-088 (Sephin1) receives orphan drug designation in the European Union for the treatment of Charcot-Marie-Tooth disease
InFlectis BioScience announces that the European Commission has granted orphan drug designation to its drug candidate IFB-088, also known as... View Article

IFB-088 (Sephin1) receives orphan drug designation in the European Union for the treatment of Charcot-Marie-Tooth disease
9 May 2025InFlectis BioScience announces that the European Commission has granted orphan drug designation to its drug candidate IFB-088, also known as... View Article

CESTI IHU: Predicting transplant rejection to better anticipate it
The objectives of the programs led by Dr. Sophie Brouard and Pr. Antoine Magnan within the CESTI IHU are to... View Article

CESTI IHU: Predicting transplant rejection to better anticipate it
9 May 2025The objectives of the programs led by Dr. Sophie Brouard and Pr. Antoine Magnan within the CESTI IHU are to... View Article

Maryvonne Hiance elevated to the rank of Officer of the Legion of Honor
Maryvonne Hiance, Vice President of Atlanpole Biotherapies cluster and manager of Effimune, was given the insignia of Officer of the... View Article

Maryvonne Hiance elevated to the rank of Officer of the Legion of Honor
9 May 2025Maryvonne Hiance, Vice President of Atlanpole Biotherapies cluster and manager of Effimune, was given the insignia of Officer of the... View Article